Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting recombinant therapeutics to circulating red blood cells

Targeting recombinant therapeutics to circulating red blood cells

US Patent 8333973 · Granted Dec 18, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thr2025
Atomic description of immune complex that causes heparin-induced thrombocytopeni2025
Atomic description of immune complex that causes heparin-induced thrombocytopeni2024
Fusion proteins and antibodies targeting human red blood cell antigens2023
Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thr2022
Atomic description of immune complex that causes heparin-induced thrombocytopeni2022
Methods and compositions for drug delivery2021
Methods for organ regeneration2021
Atomic description of immune complex that causes heparin-induced thrombocytopeni2019
Targeted carriers for intracellular drug delivery2017
Targeted protein replacement for the treatment of lysosomal storage disorders2017
Uniform field magnetization and targeting of therapeutic formulations2015